The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially ...

Eli Lilly plans to launch its experimental oral weight-loss drug orforglipron in India, a senior executive said on Thursday, ...

Novo Nordisk (NVO) has cemented itself as the leader in the booming weight-loss drug market with blockbuster treatments like ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

The Cleveland Clinic found in a September report that individuals with a version of the gene Neurobeachin were more likely to ...

Though the trial for patients with obesity and type 2 diabetes will come to an end, an obesity-only trial will continue.

Both companies have significant upside and offer robust dividend programs. Even so, Apple rebounded over the past few months, ...

Should the weight-loss pioneers be bracing for more lean years, then? Not necessarily. For although being first did not ...

“Semaglutide hits one receptor. It was the first one that came out,” he said. “Tirzepatide hits two receptors, and studies ...

Morgan Stanley downgraded Novo Nordisk to underweight from equal-weight saying it sees slowing growth of its lucrative GLP-1 ...